《滬深兩市》中央匯金托市A股三大指數全日升3.2%至6.7%成交大增 券商、醫藥及半導體股走高
人民銀行今日(6日)進行3,390億元人民幣(下同)14天期逆回購操作,中標利率持平於1.95%,單日淨回籠2,240億元。人民幣兌美元中間價今下調12點,報7.1082。中央匯金擴大ETF增持範圍。中證監連續發文表示,要求上市公司採取不同措施提升投資價值。A股三大指數低開後顯著反彈,午後愈升愈有,上證最高見2,802點。深成及創板反彈逾6%。
滬指全日收報2,789點,升67點或3.2%,成交額4,412億元。深成指收報8,460點,大升495點或6.2%,成交額4,851億元。創業板收報1,667點,大升104點或6.7%,成交額1,985億元。
中資金融股穩升,建行(601939.SH)及工行(601398.SH)分別升0.3%及0.6%。農行(601288.SH)續創新高,全日升1.7%。中行(601988.SH)升0.5%。
券商股午後顯著向上,西部證券(002673.SZ)及華林證券(002945.SZ)漲停,東北證券(000686.SZ)揚8.8%。
龍頭內房股先跌後升,萬科(000002.SZ)、金地集團(600383.SH)及保利發展(600048.SH)升1.7%至3.6%。
醫藥及醫療相關股走高,艾德生物(300685.SZ)及萬泰生物(603392.SH)漲停。英科醫療(300677.SZ)漲近19%。藥明康德(603259.SH)先跌後反彈,全日倒升8.3%。「藥茅」恆瑞醫藥(600276.SH)漲9.6%。
半導體股持續走高,華天科技(002185.SZ)漲停,納芯微(688052.SH)、捷捷微電(300623.SZ)及南大光電(300346.SZ)漲15.2%至19.2%。中芯(688981.SH)亦升4.7%;華虹(688347.SH)升8.3%。
寧德時代(300750.SZ)升4.2%。比亞迪(002594.SZ)升2.9%。
中免(601888.SH)獲美國資本集團增持,股價揚6.2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.